Various effects of FXN on obesity parameters have been observed with regard to body weight, visceral fat, adipose tissue size, fasting blood glucose concentrations, plasma insulin levels, and lipid and cholesterol metabolism rates, among others (Table 1). The gene discussed is INS; the disease is Obesity.